Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals is a biopharmaceutical company that develops and commercializes injectable and inhalable therapeutic products.
Price history of Amphastar Pharmaceuticals Inc
Price history of Amphastar Pharmaceuticals Inc
Performance & Momentum
Strategic Analysis
Amphastar Pharmaceuticals Inc • 2026
Amphastar Pharmaceuticals positions itself as a niche pharmaceutical player focused on injectable drugs, respiratory treatments, and certain specialty products. Its model is built on a combination of complex generics and products with higher technical barriers, allowing it to stand apart from a simple manufacturer of standardized generics.
- Industrial expertise in injectable and respiratory formulations, which are more technical segments than traditional generics
- Diversified portfolio across generics, specialty products, and development activities, reducing dependence on a single molecule
- U.S. presence in a regulated market where manufacturing capacity and compliance are a competitive advantage
- Exposure to generic drug pricing pressure, which can weigh on margins
- Fragile stock market performance over several years, reflecting limited visibility and sensitivity to operational setbacks
Momentum is positive in the short term, suggesting a renewed interest from the market after a pronounced decline over the medium and long term. This improvement still needs to be confirmed by more consistent operational execution, as the profile remains that of a cyclical, specialized stock rather than a linear growth story.
Similar stocks to Amphastar Pharmaceuticals Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
